Colon-specific delivery of resveratrol: Optimization of multi-particulate calcium-pectinate carrier

被引:73
作者
Das, Surajit [1 ]
Ng, Ka-Yun [1 ]
机构
[1] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore
关键词
Resveratrol; Calcium-pectinate; Colon-specific; Beads; Polyethyleneimine; Hardening agent; INTESTINAL CACO-2 CELLS; DRUG-DELIVERY; GEL BEADS; BETA-LACTAMASES; ORAL DELIVERY; IN-VITRO; RELEASE; MODEL; RATS; MICROSPHERES;
D O I
10.1016/j.ijpharm.2009.10.016
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
This study aimed at devising multi-particulate calcium-pectinate (Ca-pectinate) bead formulations for colon-targeted delivery of resveratrol. As Ca-pectinate beads were not sufficient to endure the upper GI environment and premature release of resveratrol occurred before their arrival to the colon, the beads were hardened by adding polyethyleneimine (PEI) in the cross-linking solution The effects of PEI concentration, cross-linking time, and pectin to resveratrol ratio were investigated on beads' characteristics, encapsulation efficiency, swelling-erosion, and resveratrol retention pattern of formulated beads. Proper conditions were optimized from these studies and optimized beads were further subjected to morphological examination. Formulated beads were spherical with similar to 1 mm diameter. Addition of PEI to the cross-linking solution and a minimum cross-linking time were found to be crucial factors for colon-specific release of resveratrol. As PEI was added in the cross-linking solution, hardening of the bead surface occurred simultaneously with bead formation. Observations from the present study revealed that optimized Ca-pectinate beads hardened with PEI can efficiently encapsulate resveratrol and have potential for colon-specific delivery to the lower GI tract. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:20 / 28
页数:9
相关论文
共 30 条
[2]
In vitro evaluation and modification of pectinate gel beads containing trimethyl chitosan, as a multi-particulate system for delivery of water-soluble macromolecules to colon [J].
Atyabi, F ;
Majzoob, S ;
Iman, M ;
Salehi, M ;
Dorkoosh, F .
CARBOHYDRATE POLYMERS, 2005, 61 (01) :39-51
[3]
Advances in colonic drug delivery [J].
Basit, AW .
DRUGS, 2005, 65 (14) :1991-2007
[4]
Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[5]
In vitro and in vivo evaluation of pectin beads for the colon delivery of β-lactamases [J].
Bourgeois, S ;
Laham, A ;
Besnard, M ;
Andremont, A ;
Fattal, E .
JOURNAL OF DRUG TARGETING, 2005, 13 (05) :277-284
[6]
Colonic delivery of β-lactarnases does not affect amoxicillin pharmacokinetics in rats [J].
Bourgeois, Sandrine ;
Tsapis, Nicolas ;
Honnas, Helge ;
Andremont, Antoine ;
Shakweh, Moned ;
Besnard, Madeleine ;
Fattal, Elias .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (05) :1853-1863
[7]
Evaluation of critical formulation parameters influencing the bioactivity of β-lactamases entrapped in pectin beads [J].
Bourgeois, Sandrine ;
Gernet, Muriel ;
Pradeau, Dominique ;
Andremont, Antoine ;
Fattal, Elias .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 324 (01) :2-9
[8]
DAS S, J PHARM SCI IN PRESS, DOI DOI 10.1002/JPS.21880
[9]
The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol [J].
Das, Surajit ;
Lin, Hai-Shu ;
Ho, Paul C. ;
Ng, Ka-Yun .
PHARMACEUTICAL RESEARCH, 2008, 25 (11) :2593-2600
[10]
Resveratrol as a chemopreventive agent:: A promising molecule for fighting cancer [J].
Delmas, D ;
Lançon, A ;
Colin, D ;
Jannin, B ;
Latruffe, N .
CURRENT DRUG TARGETS, 2006, 7 (04) :423-442